Myc rearrangement redefines the stratification of high-risk multiple myeloma.

Xianghong JinHui LiDingding ZhangShuangjiao LiuYuhang SongFujing ZhangZiping LiJunling Zhuang

Published in: Cancer medicine (2024)

Myc rearrangement is an independent adverse prognostic factor in NDMM. The incorporation of Myc rearrangement or multiple HRCAs into risk stratification models improves their prognostic value, providing a novel perspective on high-risk factors in NDMM.

Keyphrases

prognostic factors
risk factors
transcription factor
multiple myeloma
emergency department
adverse drug